Contributed Abstracts
Hall 1 (Salt Palace Convention Center)
Immunophenotypic, Proteomic and Genomic Characterization of Human Cord Blood (CB) Vs Peripheral Blood (PB) CD56+Dim NK Cells: A More Pro NK Phenotype in CB
*Aradhana Awasthi, PhD, New York Medical College;
*Nancy S Day, PhD, Columbia University Medical Center;
Evan Shereck, MD, Oregon Health and Science University;
Janet Ayello, MS, MT(ASCP), New York Medical College;
Anthony Sabulski, New York Medical College;
Catherine McGuinn, MD, Well Cornell Medical College;
Carmella van de Ven, MS, New York Medical College;
Megan Lim, MD, PhD, University of Michigan;
Mitchell S. Cairo, MD, New York Medical College
Double-Unit Cord Blood Transplantation (DCBT) for Acute Leukemia: High Disease-Free Survival in Adults and Children with Comparable Survival in European and Minority Patients
Juliet N. Barker, MBBS, (Hons), FRACP, Memorial Sloan-Kettering Cancer Center;
Doris Ponce, MD, Memorial Sloan-Kettering Cancer Center;
Sean Devlin, PhD, Memorial Sloan-Kettering Cancer Center;
Marissa Lubin, BA, Memorial Sloan-Kettering Cancer Center;
Katherine Evans, BA, Memorial Sloan-Kettering Cancer Center;
Anne Marie Gonzales, BS, Memorial Sloan-Kettering Cancer Center;
Hugo Castro-Malaspina, MD, Memorial Sloan-Kettering Cancer Center;
Sergio A. Giralt, MD, Memorial Sloan-Kettering Cancer Center;
Jenna Goldberg, MD, Memorial Sloan-Kettering Cancer Center;
Ann A. Jakubowski, PhD MD, Memorial Sloan-Kettering Cancer Center;
Guenther Koehne, MD, PhD, Memorial Sloan-Kettering Cancer Center;
Esperanza Papadopoulos, MD, Memorial Sloan-Kettering Cancer Center;
Miguel-Angel Perales, MD, Memorial Sloan-Kettering Cancer Center;
Craig Steven Sauter, MD, Memorial Sloan-Kettering Cancer Center;
Marcel R. M. van den Brink, MD, PhD, Memorial Sloan-Kettering Cancer Center;
James Young, MD, FACP, Memorial Sloan-Kettering Cancer Center;
Farid Boulad, MD, Memorial Sloan-Kettering Cancer Center;
Rachel Kobos, MD, Memorial Sloan-Kettering Cancer Center;
Richard O'Reilly, MD, Memorial Sloan-Kettering Cancer Center;
Susan Prockop, MD, Memorial Sloan-Kettering Cancer Center;
Trudy Small, MD, Memorial Sloan-Kettering Cancer Center;
Nancy Kernan, MD, Memorial Sloan-Kettering Cancer Center;
Andromachi Scaradavou, Memorial Sloan-Kettering Cancer Center
HLA-DP Matching Is Not Clinically Relevant in 10/10 HLA Matched Transplants: A Single Center Study
Noureddine Berka, PhD, Calgary Laboratory Services;
Desmond Koo, HS, University of Calgary;
Abdelhamid Liacini, PhD, University of Calgary;
Faisal Khan, PhD, University of Calgary;
Rehan Mujeeb Faridi, PhD, University of Calgary;
Kemp J Taylor, university of Calgary;
Jan Storek, MD, PhD, Tom Baker Cancer Centre/Foothills Hospital;
Victor Lewis, MD, Alberta Children's General Hospital
Levels of ANTI-HLA DONOR Specific Antibodies (DSA) and GRAFT Outcome in Allogeneic Hematopoietic STEM CELL Transplant
Kai Cao, MS, MD D(ABHI), The University of Texas MD Anderson Cancer Center;
Marcelo Fernandez-Vina, PhD, D(ABHI), Stanford University Medical School;
Titus H Barnes, CHS(ABHI), UT MD Anderson Cancer Center;
Hemantkumar S. Patel, CHS(ABHI), UT MD Anderson Cancer Center;
Yudith Carmazzi, UT MD Anderson Cancer Center;
David Partlow, MS, MT(ASCP), CHS, UT MD Anderson Cancer Center;
Pedro Cano, MD, MBA, UT MD Anderson Cancer Center;
Richard E. Champlin, MD, MD Anderson Cancer Center;
Stefan O. Ciurea, MD, The University of Texas MD Anderson Cancer Center
Incidence, Nature, Risk Factors and Outcomes of Cytomegalovirus Infection After Double-Unit Cord Blood Transplantation
Parastoo Dahi, MD, Memorial Sloan-Kettering Cancer Center;
Amanda L. Olson, MD, Memorial Sloan-Kettering Cancer Center;
Sean Devlin, PhD, Memorial Sloan-Kettering Cancer Center;
Marissa Lubin, BA, Memorial Sloan-Kettering Cancer Center;
Anne Marie Gonzales, BS, Memorial Sloan-Kettering Cancer Center;
Katherine Evans, BA, Memorial Sloan-Kettering Cancer Center;
Andromachi Scaradavou, Memorial Sloan-Kettering Cancer Center;
Nancy Kernan, MD, Memorial Sloan-Kettering Cancer Center;
Trudy Small, MD, Memorial Sloan-Kettering Cancer Center;
Richard O'Reilly, MD, Memorial Sloan-Kettering Cancer Center;
Sergio A. Giralt, MD, Memorial Sloan-Kettering Cancer Center;
Guenther Koehne, MD, PhD, Memorial Sloan-Kettering Cancer Center;
Miguel-Angel Perales, MD, Memorial Sloan-Kettering Cancer Center;
Doris Ponce, MD, Memorial Sloan-Kettering Cancer Center;
Zenia Papanicolaou, MD, Memorial Sloan Kettering Cancer Center;
Juliet N. Barker, MBBS, (Hons), FRACP, Memorial Sloan-Kettering Cancer Center
Long Term Outcomes of Pediatric Patients with Sickle Cell Disease Who Underwent a Reduced Intensity T Cell Depleted Haploidentical Transplantation
Mari Hashitate Dallas, MD, St. Jude Children's Research Hospital;
David Shook, MD, St. Jude Children's Research Hospital;
Ashok Srinivasan, MD, St.Jude Children's Research Hospital;
Christine Mary Hartford, MD, St. Jude Childrens Research Hospital;
Brandon Matthew Triplett, MD, St Jude Childrens Research Hospital;
Wing Leung, MD, PhD, St. Jude Children's Research Hospital
Grandparents Are Invaluable People As HLA-Matched Donors in Hematopoietic Stem Cell Transplantation
Amir Ali Hamidieh, M.D., Tehran University of Medical Sciences;
Mohammadreza Ostadali, M.D., Tehran University of Medical Sciences;
Maryam Behfar, M.D., Tehran University of Medical Sciences;
Sirous Tayebi, Tehran University of Medical Sciences;
Ashraf sadat Hosseini, Tehran University of Medical Sciences;
Arash Jalali, Tehran University of Medical Sciences;
Ardeshir Ghavamzadeh, M.D., Tehran University of Medical Sciences
Contrasting Patterns of Alloreactivity Amongst Malignant and Nonmalignant Diseases Receiving Haploidentical PBSC GRAFT and Post-Transplant Cyclophosphamide
Sarita Jaiswal, MD, APOLLO GLENEAGLES CANCER HOSPITAL;
Ujjwayini Ray, MD, APOLLO GLENEAGLES HOSPITAL;
Suman Podder, APOLLO GLENEAGLES CANCER HOSPITAL;
Sipra Senapati, APOLLO GLENEAGLES CANCER HOSPITAL;
Sumita Chatterjee, MSc, MTech, APOLLO GLENEAGLES HOSPITAL;
Basudevi Mishra, Apollo GLENEAGLES Cancer Hospital;
Swati Modak, Apollo GLENEAGLES Cancer Hospital;
Suparno Chakrabarti, MD, FRCPATH, MANASHI CHAKRABARTI FOUNDATION
Decision Analysis of Donor Selection in Allogeneic Stem Cell Transplantation for Patients with Acute Leukemia in First Remission-Related Donor with HLA-1 Antigen Mismatch in the Gvh Direction Vs. HLA-8/8 Allele-Matched Unrelated Donor
Junya Kanda, MD, PhD, Saitama Medical Center, Jichi Medical University;
Akiyoshi Takami, MD, PhD, Kanazawa University Graduate School of Medical Sciences;
Junji Tanaka, MD, PhD, Stem Cell Transplantation Center, Hokkaido University Hospital;
Koichi Miyamura, MD, PhD, Japanese Red Cross Nagoya First Hospital;
Kazuteru Ohashi, MD, PhD, Tokyo Metropolitan Cancer and Infectious diseases Center;
Takahiro Fukuda, MD, PhD, National Cancer Center Hospital;
Yukiyasu Ozawa, MD, PhD, Japanese Red Cross Nagoya First Hospital;
Yasuo Morishima, MD, PhD, Aichi Cancer Center Research Institute;
Hisashi Sakamaki, MD, PhD, Tokyo Metropolitan Cancer and Infectious diseases Center;
Yoshiko Atsuta, MD, PhD, Nagoya University Graduate School of Medicine;
Yoshinobu Kanda, MD, PhD, Saitama Medical Center, Jichi Medical University
Missing KIR-Ligands in Single Mismatched Unrelated Hematopoietic Stem Cell Transplantation
Christine Zollikofer, MSc, Institute for Clinical Transfusion Medicine and Immunogenetics Ulm gGmbH (IKT);
Daniel Fürst, MD, Institute for Clinical Transfusion Medicine and Immunogenetics Ulm gGmbH (IKT);
Hubert Schrezenmeier, MD, Institute for Clinical Transfusion Medicine and Immunogenetics Ulm gGmbH (IKT);
Joannis Mytilineos, MD, PhD, Institute for Clinical Transfusion Medicine and Immunogenetics Ulm gGmbH (IKT)
![[Visit Client Website]](images/banner.gif)